Wall Street Analyst Ratings: United Therapeutics, BILL Holdings, Ambarella & More

Wall Street analysts have been busy adjusting their price targets and ratings for a number of companies this week. Here’s a rundown of some of the most notable changes:

*

United Therapeutics Corporation (UTHR):

Oppenheimer raised the price target from $400 to $575, maintaining an Outperform rating. The stock closed at $349.23 on Tuesday, up 0.7%.
*

BILL Holdings, Inc. (BILL):

Mizuho lowered the price target from $60 to $52, keeping a Neutral rating. Despite the downgrade, BILL Holdings shares gained 7.5% to close at $53.48 on Tuesday.
*

Ambarella, Inc. (AMBA):

Craig-Hallum boosted the price target from $80 to $85, maintaining a Buy rating. Ambarella shares closed at $52.79, up 3.2% on Tuesday.
*

Albemarle Corporation (ALB):

Evercore ISI Group cut the price target from $190 to $170, while maintaining an Outperform rating. The stock closed at $88.98, up a slight 0.04% on Tuesday.
*

Cognizant Technology Solutions Corporation (CTSH):

RBC Capital raised the price target from $81 to $82, maintaining a Sector Perform rating. Cognizant Technology shares rose 0.4% to close at $77.15 on Tuesday.
*

Nordstrom, Inc. (JWN):

B of A Securities raised the price target from $18 to $20, but maintained an Underperform rating. Nordstrom shares fell 2.5% to close at $21.14 on Tuesday.
*

The Toro Company (TTC):

Baird increased the price target from $100 to $102, keeping a Neutral rating. Toro Company shares gained 0.2% to close at $90.60 on Tuesday.
*

Twilio Inc. (TWLO):

Bernstein boosted the price target from $68 to $70, maintaining a Market Perform rating. Twilio shares gained 2.2% to close at $61.99 on Tuesday.
*

Ulta Beauty, Inc. (ULTA):

Deutsche Bank cut the price target from $552 to $448, but maintained a Buy rating. Ulta Beauty shares fell 1% to close at $371.35 on Tuesday.
*

Delek Logistics Partners, LP (DKL):

Citigroup raised the price target from $44 to $45 and upgraded the stock from Neutral to Buy. Delek Logistics Partners shares fell 0.4% to close at $38.83 on Tuesday.

It’s important to remember that analyst ratings and price targets are just one piece of the puzzle when it comes to investment decisions. Investors should always conduct their own research and consult with a financial advisor before making any investment choices.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top